Photoprotection by sunscreens with topical antioxidants and systemic antioxidants to reduce sun exposure

J Long Term Eff Med Implants. 2004;14(4):317-40. doi: 10.1615/jlongtermeffmedimplants.v14.i4.40.

Abstract

Skin cancer is the most common cancer diagnosed in the United States, and its incidence continues to rise. Epidemiological studies have documented that excessive sun exposure increases the risk of developing nonmelanoma skin cancer. Consequently, it is mandatory that the skin be protected from the damage that occurs from ultraviolet (UV) exposure. It is the purpose of this report to review the scientific basis for photoprotection by sunscreens, topical antioxidants, and systemic antioxidants to minimize the harmful effect of sun exposure. The US Food and Drug Administration regulates sunscreen products as over-the-counter drugs. Sunscreens are chemical or organic UV absorbers and nonchemical or inorganic UV absorbers. Other important sunscreen considerations include the sunscreen vehicle, sunscreen photostability, sunscreen preservatives, and sunscreen photoallergy and phototoxicity. Topical and systemic antioxidants have now been shown to supplement the photoprotective effects of sunscreen. The Skin Cancer Foundation, the only national and international nonprofit organization concerned exclusively with cancer of the skin, is playing a leadership role in eliminating skin cancer in our world.

Publication types

  • Review

MeSH terms

  • Administration, Topical
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use*
  • Antioxidants / administration & dosage
  • Antioxidants / therapeutic use*
  • Dose-Response Relationship, Radiation
  • Humans
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / etiology
  • Skin Neoplasms / prevention & control*
  • Sunscreening Agents / therapeutic use*
  • Ultraviolet Rays / adverse effects

Substances

  • Adrenal Cortex Hormones
  • Antioxidants
  • Sunscreening Agents